Forte Biosciences, Inc.

NASDAQ:FBRX

Biotechnology

Healthcare
$76.99 +1.71%

+$0.30 today

Market cap
$1.58B
Beta
2.87
P/E (TTM)
-42.1
EPS (TTM)
-$0.43
52W Low $9.10High $35.80

Volume 0.00M

Average 0.30M

Price history

Forte Biosciences, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+311.49%

Period high

$76.99

Period low

$15.67

Latest

$76.99

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 14D9/AAug 21, 2026Aug 21, 2026
SC 14D9/AAug 19, 2026Aug 19, 2026
SC TO-T/AAug 19, 2026Aug 19, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
10-QAug 12, 2026Aug 12, 2026
SC 13G/AAug 12, 2026Aug 12, 2026
SC 13GAug 11, 2026Aug 11, 2026
SC 13G/AAug 7, 2026Aug 7, 2026
SC 13G/AAug 7, 2026Aug 7, 2026
SC TO-TAug 6, 2026Aug 6, 2026
SC TO-T/AAug 6, 2026Aug 6, 2026
SC 14D9Aug 6, 2026Aug 6, 2026
SC 13GJul 28, 2026Jul 28, 2026

Competitors

Who does Forte Biosciences, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about FBRX's filings, answered from its disclosures.

What is the latest FBRX filing?

The latest filing shown is SC 14D9/A dated Aug 21, 2026.

How many recent filings does FBRX have?

Intrinsic Alpha currently shows 20 recent filings for FBRX.